Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Computer-aided Drug Discovery Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.
The global computer-aided drug discovery (CADD) market is expected to grow from $3.75 billion in 2023 to $7.81 billion by 2030, at a CAGR of 11.1% during the forecast period (2023-2030).
This report provides a holistic understanding of the CADD market, including market sizing, forecasts, drivers, challenges, and the competitive landscape.
Market Dynamics:
Drivers
- Growing Prevalence of Chronic Diseases: The increasing incidence of chronic diseases is boosting the demand for advanced drug discovery methods, driving the growth of the CADD market.
- Rising Adoption of Artificial Intelligence (AI) and Big Data: The adoption of AI and big data in drug discovery processes is streamlining research efforts and is expected to fuel market expansion.
Challenges
- Lack of Skilled Labor: The shortage of skilled professionals proficient in CADD tools could hinder market growth.
- Lower Product Penetration in Emerging Economies: Limited access to advanced technologies and economic constraints may slow down CADD adoption in emerging economies.
Market Segmentation:
By Type
- Drug Design: This segment includes ligand-based drug design and sequence-based approaches.
By Therapeutic Area
- Neurology, Oncology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others: CADD techniques find applications across various therapeutic areas, with significant growth potential in neurology, oncology, and cardiovascular disease drug discovery.
By End User
- Biotechnology Companies, Pharmaceutical Companies, Research Laboratories: The CADD market serves biotechnology and pharmaceutical firms, as well as research laboratories engaged in drug discovery efforts.
By Region
- Europe, North America, Asia Pacific, Latin America, Middle East & Africa: The market spans major regions, with North America and Europe being key markets, and Asia Pacific expected to witness substantial growth in CADD adoption.
Historical & Forecast Period:
- Base Year: 2022
- Historical Period: 2018-2022
- Forecast Period: 2023-2030
Profiles of Key Companies:
The report offers detailed profiles of companies operating in the global computer-aided drug discovery market.
Companies Mentioned
- Albany Molecular Research Inc. (AMRI).
- Aragen Life Sciences Pvt. Ltd.
- Aris Pharmaceuticals Inc
- AstraZeneca
- Bayer AG
- Bioduro-Sundia
- BOCSCI Inc.
- Charles River Laboratories
- GVK Biosciences
- Schrodinger Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 137 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $3.75 Billion |
| Forecasted Market Value (USD) by 2030 | $7.81 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/hmiwdi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
